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Objectives.
fin a
porcine coronary model, fibrin flits soaked far
3 h in heparin was used as a circumferential coating on a tantalum
stint to assess the effect of this naturally occurring blopolymer on
arterial healing. The results were compared with those obtained
with medical grade polyurethane-coated stainless steel stengs .
Background. Thrombus plays an important role in healing
after arterial injury and may affect the development of neoinfiffial
hyperplasia. Manipulation of the initial thrombus may alter the
healing response . To study this, we placed a template of fibrin in
a porcine coronary artery restenosis model .
Methods. Thirty-four fibrin film stents were delivered in 20
swine. Oversizing was avoided, to prevent deep arterial injury, by
placement of optimally sized stents . Initial patency of the stentecl
vessel was confirmed by angiography .
Results . Three fibrin-stented swine died within 40 h ; in each,
the stem was occluded with a fibrin/red blood cell mass. In two of
Intracoronary stents are finding increasing use for the treat-
ment of suboptimal results of conventional dilation or for
prevention of restenosis in selected patient subsets (1-5) .
The primary problems with current metallic stents include
subacute closure and restenosis. These problems have en-
couraged interest in other stent materials such as polymers .
Synthetic polymers, either biostable or biodegradable, would
have the potential advantage of providing mechanical sup-
port for intimal dissections but also could act as a vehicle
for local drug delivery to prevent restenosis . Initial experi-
ence with various synthetic polymers in different animal
models produced variable results (6,7). With some biode-
gradable polymers in a porcine model, severe tissue reaction
has been identified (6,7) . Polyurethane has been widely used
for vascular applications, including permanent pacemaker
leads. Given the wide experience with this
polymer, we
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these three, a portion of the exogenous fibrin had become detached
from the stint and partially occluded the lumen . Of the remaining
31 stints, all were patent at elective sacrifice of 28 days . Eighty-
four percent had a diameter stenosis <50%, and the mean (±SD)
diameter stenosis was 32 .3 ± 13%. There was no evidence of
significant foreign-body giant-cell reaction . These results con-
trasted with the medical grade
polyurethane-coated
gents placed
according to the same protocol without oversizing. Twelve of these
stents were placed ; six swine died of thrombotic occlusion within
the 1st 48 h. At elective sacrifice at 28 days, the remaining
polyurethane-coated stents were occluded by marked neointimal
hyperplasia.
Conclusions. Fibrin film-coated stents seem promising as a
template for modifying the local response to arterial injury and for
potentially decreasing eestenosis rates.
(J Am Coil Cordial 1994,24 :52S-31)
considered polyurethane as a potential scent coating . An-
other alternative is the native biopolymer fibrin . Native
fibrin is deposited after arterial injury, colonized and reab-
sorbed, and it may serve as a template for the degree of
eventual neointimal thickness (8,9) . The goals of this study
were to assess the response of the arterial wall to exogenous
fibrin sleeves placed in a porcine coronary artery model and
to compare it with a medical grade polyurethane-coated
stent sleeve.
Methods
Animals. All studies were conducted with the approval of
the Animal Care and Use Committee of the Mayo Clinic . A
juvenile, domestic, crossbred swine coronary model was
used, as previously described (10) . Swine were fed a normal
laboratory chow diet without cholesterol supplementation
.
Premedication with a single dose of aspirin (650 mg) and
verapamil (sustained release, 120 mg) was administered
within 24 h before coronary arterial stenting . Ketamine
(12 mg/kg body weight) and xylazine (8 mg/kg) were given
intramuscularly for general anesthesia
. Atropine (I mg) was
0735-1097194/$7.00
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used intramuscularly to decrease oropharyngeal secretions,
and flocillin (t g) was given prophylactically for infection .
Arterial access was obtained through carotid arterial
cutdown after infiltration of the ventral neck region with
10 ml of 1% xylocaine (10) . The right external carotid artery
was exposed, and an SF hemostatic sheath was placed for
arterial' access . A single heparin bolus of 10,000 U was
administered through the sheath .
t of coronary sleet. After carotid artery cut-
down, the coronary angioplasty balloon with the stent was
positioned in the coronary artery over a standard guide wire
with fluoroscopic guidance . Oversizing was avoided to pre-
vent deep arterial injury (10). Stents were placed in the right
coronary, circumflex or left anterior descending coronary
arteries . Fluoroscopy with injection of contrast material
immediately after implantation of the coil confirmed ade-
quate coil expansion and vessel patency . The carotid arted-
otomy was repaired with standard techniques or ligated if
repair was not possible . The neck wound was closed with
interrupted sutures, and the animals were returned to their
quarters for observation . No antiplatelet agents or additional
anticoagulants were used after the initial heparin dose .
At 28 days, the animals were killed with a commercial
intravenous euthanasia solution (Sleepaway, Fort Dodge
Laboratory, 10 ml through an ear vein). The hearts were
removed immediately, and the coronary arteries were fixed
by pressure perfusion (100 mm Hg) with 10% neutral buff-
ered formalin for 24 h . After fixation, the stented coronary
segments were dissected free . Sections were made at 2-mm
intervals perpendicular to the long axis of the vessel with the
stent still in place. The residual metal fragments were then
removed, and the tissue from each segment was embedded
and stained with hematoxylin-eosin and elastic-van Gieson .
All histopathologic measurements were made by an experi-
enced cardiac pathologist (W.D.E .) with digital microscopy .
The major and minor axes of both the original and
stenotic (residual) vessel lumens were measured, as were
the areas of the original and stenotic lumens . The percent
area of stenosis was calculated as % Stenosis = 100 x (1 .0 -
[Stenotic lumen area/Original lumen area]) . The minimal
lumen diameter was also measured .
The relation between vessel injury and neointimal re-
sponse was measured from the elastic-van Gieson-stained
sections, as previously described (8,10) . Vessel injury at
each wire site was measured with a previously described
ordinal injury score . This score increases with the depth of
arterial injury and varies from least injury (0) through
maximal injury (3). Mean arterial injury score for any given
section was calculated as mean injury at all wire sites in that
section
: Mean injury score = (Sum of scores for each wire{
Number of wires present) .
The neointimal thickness at each wire site was measured,
and the mean thickness for all wire sites was then used to
calculate the injury response . For each injured artery there
was, therefore, a mean injury score and a mean neointimal
thickness .
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Figure 1 . Fibrin sleeve configured as a thin, balloon-expandable
cylinder. Embedded within the fibrin is a tantalum metal wire stent .
The viscoelastic properties of the fibrin make it easily able to be
crimped on an angioplasty balloon and expanded in a coronary
artery as a long-term implant .
Experimental groups. There were two groups: fibrin-
coated tantalum sleeve stents (group 1), and medical grade
polyurethane-coated sleeve stainless steel stents (group 2).
Fibrin-coated tantalum steals . Fibrin was prepared for
placement on the tantalum stent as follows . Porcine fibrino-
gen was isolated from pig whole blood with standard over-
night cryoprecipitation methods. Whole blood was collected
with citrate phosphate dextrose or citrate phosphate dextrose
adenine anticoagulant solution . 'The whole blood was centri-
fuged for 10 min at 4,500 x g, and the plasma was transferred
to an attached satellite bag . The plasma was frozen at -70°C
for a minimum of 12 h . The frozen plasma was then placed in
a refrigerator at 4°C and allowed to thaw 6 to 12 h until all
residual ice crystals were gone . The plasma was centrifuged
for 10 min at 4,500 x
g
at 4°C . The supernatant plasma was
siphoned into satellite bags, and concentrated fibrinogen in a
measured concentration of 500 to 800 mg/dl was left .
The fibrin was placed on a standard balloon expandable
stent (Wiktor, Medtronic) as follows . Concentrated porcine
thrombin, 1,000 U/ml, was used to precipitate the fibrinogen .
The fibrin was then formed on the tantalum stent by dripping
the fibrinogen solution and thrombin solution from separate
syringes directly on the stent . Polymerization of the fibrin
occurred around the scent; this formed a fibrin mass com-
pletely encasing the stent (Fig . 1). The fibrin was com-
pressed to a thin (0 .005-in . [0 .012 cm]) film and then soaked
in a heparin solution for 3 h. The devices were then crimped
onto standard collapsed angioplasty balloons and delivered
to the coronary artery .
Polyurethane-coated stents . The synthetic polymer films
were biostable medical grade polyurethane, synthesized as
follows . The films were cast from solvent by pouring the
solvent-dissolved polymer over a 0 .005-in. tantalum wire
that was bent in the form of a sine wave, with an amplitude
of 1 cm and a length of 1 cm . Curing was achieved in an oven
at 50°C for 48 h . The films were removed by first covering
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Figure 2. Medical grade polyurethane films were prepared by pour-
ing the solvent-dissolved polymer over a 0.005-in . wire bent in the
form of a sine wave . After curing, films containing the wire were cut
anti wrapped around angioplasty balloons .
them with 100% reagent alcohol and then cutting around the
edges of the circular container. Each film was between 0 .003
and 0.005 in . (0.007 to 0.012 cm) thick (Fig . 2) .
Individual films were prepared for implantation by cutting
a rectangle around the tantalum sine waves . The tantalum
was entirely covered by the polyurethane film as a result of
the casting process . The films were then wrapped around
standard (collapsed) 3 .0-mm angioplasty balloons, ready for
delivery to the coronary arteries using standard over-
the-wire techniques . Inflation of the balloon resulted in
unwrapping of the film-tantalum combination, and with-
drawal of the balloon caused the film to form a cylinder lining
the wall of the artery --1 cm in length .
Statistical methods. The slopes and intercepts for com-
bined arterial segments were determined with linear regres-
sion according to standard methods (Systat) . This analysis
allowed direct comparison of the arterial injury-response
relation.
Results
Group 1 . Thirty-four fibrin film stents were delivered in
20 swine (Table 1). All swine had patent vessels at angiog-
raphy 15 min after stent placement . Three of these animals
died within 48 h; at pathologic examination, the three stenis
were occluded, presumably resulting in an arrhythmic death .
In each of these three swine, the occlusion was related to a
fibrin/red blood cell mass . In two of them, a portion of the
exogenous fibrin had become detached from the stent and
partially occluded the lumen . This may have resulted in the
subsequent occlusion .
Of the remaining 31 stents, all were patent at elective
sacrifice at 28 days (Fig . 3). The minimal lumen diameter of
the stented segments was 1 .53 ± 0.46 mm (range 0 .93 to
3.05). The distribution of the minimal lumen diameter is
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Table 1
. Mean Injury Score, Neointirnal Thickness and Sie osis
After Implantation of Fibrin Stent
LAD = left anterior descending coronary artery
; LCx = left circumflex
coronary artery ; RCA = right coronary artery
.
shown in Figure 4 . Mean diameter stenosis was 32 .3 ± 13%,
and mean area stenosis was 52.6 ± 16.6%. The distribution
of the area and diameter stenoses is shown in Figure 5 .
Eighty-four percent of the segments had a residual diameter
stenosis <50%, and there were no occlusions .
Histologically, the fibrin was structurally intact, and it
was completely endothelialized in all stented segments . The
degree of neointimal thickening during the lime after implan-
tation was similar to that previously reported in this porcine
model . There were no large collections of foreign-body giant
cells . Finally, local vascular integrity was
maintained, with-
out medial necrosis (Fig . 3) .
Mean neointimal thickness was 0 .56 ± 0.19 mm (range
0.29 to 0 .04)
. Although this model was not intentionally
oversized, the degree of arterial injury varied (Table 1)
. The
relation between neointimal thickness, neointimal area and
Vessel
No .
Animal
No .
Vessel
Mean
Injury
Score
Mean
Neoiatinial
Thickness
(mm)
Diameter
Saencsis
(%)
1 1
LCx 1 .86 0 .36 9
.1
2 1 RCA 2 .0
0.29 15 .6
3
2 LCx 3 .0 0 .72
54 .6
4 2 RCA
2 .5 0 .77 42 .5
5 3 LAD
2 .14 0.44 22 .7
6 3 LCx 2 .29
0 .62 21 .7
7 3
RCA 3 .0 0.95 59
.5
8 4 LAD
2 .4 0 .53 30 .4
9 4 LCx 2 .8 0.59
34 .7
10 4 RCA 3 .0 0.84
21 .2
11 5
LAD 3 .0 0 .84 57 .5
12 5
LCx 3 .0 0.73 24 .5
13 5 RCA 3 .0 0
.88 51 .5
14 6 LCx 2 .33 0 .36
23 .7
I5 6 RCA 1 .33 0 .34 14 .9
16 7
LCx 1 .88 0.35 26 .7
17 S LAD
2 .2 0 .33
21 .7
L9 9 LAD 2 .0 0 .39 23 .1
19 10 LAD 2 .0 0 .59 28 .7
20 10 RCA 2 .5 0.70 39 .2
21 II LCx 2 .43 0.36 31 .7
22 12 RCA 2 .2 0 .38 35 .0
23 13 LCx 1 .83 0 .33 25 .8
24 13 RCA 2.0
0 .48
27
.4
25
14 LCx 3 .0 0 .84 54 .6
26 14 RCA 2 .67 0 .67 29 .1
27 15 LCx 2.33 0 .52 25 .3
28
15 RCA 2.0 0 .37 14 .8
29 16 LCx 3 .0 0 .65 41 .9
30 16 RCA 2 .6 0
.59
39.6
31 17 RCA 2 .5
0 .78 44 .7
Mean
0 .56 32 .3
±SD
±0 .19 ±13
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injury score is shown in Figure 6 . The regression equation
was area = 0.36 x injury score - 0.30. Even with more
severe injury scores (>2.0), the mean neointimal thickness
typically remained < 1 mm .
Group 2. Twelve circumferentially coated polyurethane
metallic scents were placed . Six of these swine died within
the Ist 48 h after implantation . At elective sacrifice at 28
days, the remainder of the stems were occluded . A mass of
neointimal thickening completely obliterated the lumen in
each. The area and diameter stenosis, therefore, were 1 0
in each .
Histologic examination documented an intense foreign-
body inflammatory reaction with multinucleated giant cells
Flgwt 4. Distribution of minimal lumen diameter in 31 porcine
coronary arteries with fibrin film stems .
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in each stent, in addition to severe neointimal thickening and
occlusion (Fig. 7). The relation between neointimal thick-
ness and degree of arterial injury could not be calculated
because the stent was occluded in each .
Figure 5 . Distribution of diameter (top) and area (bottom) stenosis in
31 porcine coronary arteries with fibrin film scants .
100,
Figure 3. Fibrin scent at 28 days. A
thin layer of fibrin remains, with
only mild aeointimal thickening .
Uematoxylin-eosin x7 .5, reduced
by 15% .
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Figure 6 . Injury-neointimal thickness regression line for the fibrin
sleeve stents . Although there is a persistent relation, as previously
described, between arterial injury and thickness, it is less than that
previously described (9) . Even with more severe injury, the thick-
ness remained typically < I mm,
Discussion
Intracoronary metallic stents are being used with increas-
ing frequency to treat dissections and abrupt closure during
percutaneous transluminal coronary angioplasty and poten-
tially to decrease restenosis rates (1-5) . Because of the
potential problems of permanent intraarterial metallic im-
plants, including acute and subacute thrombotic closure and
the finding that restenosis remains a substantial problem
with current metallic designs, there has been interest in the
development of polymeric stents . These could be either
biostable or biodegradable and could potentially be used as
vehicles for local drug delivery and as a scaffold to treat
dissections or abrupt closure .
Multiple polymeric materials are being tested for intra-
coronary implants. We have reported the initial outcome of
polyethylene terephthalate stents in a porcine coronary
model without oversizing (6) . Of seven swine surviving 4 to
6 weeks after stent implantation, the stented segment was
occluded in each, with massive neointimal thickening . In
that stent model, there were. two histologic patterns : a
chronic foreign-body inflammatory response and a central
neointimal response . The latter was morphologically similar
to that seen in human restenotic tissue obtained at the time
of directional atherectomy . Subsequently, in a similar por-
cine coronary model in which three other polymers were
used (polyglycolic/polylactic acid, polycaprolactone and
polyhydroxy butyrate valerate), similar severe tissue reac-
tions were also found, including extensive fibromuscular
hyperplasia, multinucleated giant cell formation and medial
necrosis (7) . Whether these severe reactions are the result of
breakdown products or result from the process of degrada-
tion itself is uncertain .
Present study. In this study, we compared two other
polymers-a biostable, biocompatible polyurethane and a
"natural" fibrin film. Polyurethane has been used exten-
sively for vascular applications and is the most widely used
HOLMES El AL
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polymer for construction of permanent pacemaker leads . It
has, however, not been widely used for arterial applications
in small vessels
. Despite its relative biocompatibility, poly-
urethane resulted in the same findings as previously de-
sc,ihed with other polymers in this model-vessel occlusion
and a foreign-body inflammatory response with multinucle-
ated giant cells, Neointimal thickening at 28 days was
marked and occluded all the stents ; in addition, there was a
high rate of thrombotic occlusion within the I st 48 h
.
These results are in striking contrast to the results with
fibrin . In 31 of the 34 stents, lumen patency was maintained
at 28 days, without severe local tissue reaction and without
severe neointimal thickening . The residual stenoses were
<50% in most swine treated with these circumferentially
coated fibrin stents . There were various degrees of neoind-
inal thickness but less than previously reported
. Typically in
this model increasing degrees of arterial injury result in a
linear increase in neointimal thickness . This finding was also
confirmed in this study . In addition, the healing response
with the fibrin sleeve was similar histologically to that with
native fibrin ; however, the implanted fibrin did last until
sacrifice at 4 weeks, whereas native fibrin usually lasts <2
weeks (9) .
In the fibrin stent group, three swine died within 48 h, and
stent occlusion was found in each . In two of these, there was
partial detachment of the fibrin from the stent and partial
occlusion of the lumen. In the third animal, no such struc-
tural problem was identified . None of the swine had received
any anticoagulant therapy after the implant . The fibrin-
coated stents had been soaked in heparin for 3 h before final
balloon preparation . Future studies will be needed to iden-
tify the requirement for this soaking or need for more
anticoagulation .
Fibrin in medical applications . The use of fibrin for med-
ical applications has been well described (11-22) . Initial
applications included its use as a dural substitute in patients
with head injuries (21) . 11 has also been used as a glue or
spray for hemostasis, for reinforcing and scaling suture and
staple lines, as an internal organ liner, and as a substrate for
in vitro endothelialization of vascular grafts (13,17-19,23) .
The latter application has the most similarity to the use
described in this study-as an implantable template to con-
trol or modify the healing response after arterial injury (19) .
In polytetrafluoroethylene vascular graft applications, fibrin
glue, which contained human fibronectin and aprotinin and
tranexamic acid (inhibitors of fibrinolysis), promoted the
formation of a sheer stress-resistant endothelial cell mono-
layer (19) . Even after 24 h of perfusion, most of the graft
surface was still covered by endothelial cells . In addition,
species-specific fibrin seems to produce little local tissue
reaction .
In addition to sealing biologic surfaces and promoting
endothelialization with little tissue reaction, fibrin also has
the potential to act as a delivery vehicle. . The matrix varies
widely depending on the conditions under which it is formu-
lated. Variations in ionic strength, pH and fibrinogen and
530
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thrombin concentration affect whether the final fibrinogen is
coarse or fine, although the first two variables are the most
important. Depending on the matrix size, the fibrin could be
used to incorporate microcapsules of various sizes for local
drug delivery .
Fibrin adon. The biodegradation of fibrin has
been studied (14,22) . The reabsorption is both enzymatic
(fibrinolysis) and cellular (phagocytosis) . The rate of reab-
sorption varies and depends on formulation, matrix size and
cross-linking . In the present series, at I month the exoge-
nous fibrin seen was still present, although it was colonized .
3ACC Vol. 24, No . 2
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Figure 7. A, Gross microscopic
photograph of polyurethane-
coated scent with complete occlu-
sion. 11, Microscopic photograph
of stent at 28 days with vessel
occlusion related to a large
amount of neointimal hyperplasia .
Elastic-van Gieson x 5, reduced
by 24% .
Presumably by varying the formulation, reproducibly con-
trolled degradation can be achieved .
There are several potential concerns about fibrin, includ-
ing issues of donor infection, specific formulation, immuno-
logic response and optimal delivery vehicle . The use of
species-specific fibrin has not been associated with signifi-
cant reactions. Whether more minor reactions may be im-
portant is unclear. The fibrin sleeve used did not prevent the
development of at least some neointimal formation in the
current series . It did, however, prevent the uniform occlu-
sion and severe tissue reaction seen with other polymers
JACC Vol . 24, No . 2
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we have studied . Whether the various neointimal formations
that were present in this series resulted from impurities in
formulation, immunologic reactions or other factors cannot
be determined .
Conclusions. This report evaluates the initial experience
with fibrin as a naturally occurring biopolymeric coating for
intracoronary stents in a porcine coronary injury model . In
contrast to medical grade polyurethane and other biopoly-
mers studied in this model, patency of the stented segment
was maintained in all animals, and the previously observed
neointimal and foreign-body tissue reaction were signifi-
cantly decreased .
The potential of fibrin as a scent or sleeve needs further
evaluation . Substantial problems need to be addressed,
including issues of donor source, specific formulation and
delivery. It does seem promising, however, as a natural
template for arterial healing that could potentially decrease
the local tissue response seen with other polymers or devices
and that could modify the "restenotic" process after arterial
injury .
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